Congress Park Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
6,838
-113
-2% -$26.3K 0.47% 46
2026
Q1
$1.7M Sell
6,951
-634
-8% -$148K 0.52% 46
2025
Q4
$1.57M Sell
7,585
-76
-1% -$15K 0.47% 50
2025
Q3
$1.42M Sell
7,661
-586
-7% -$100K 0.44% 47
2025
Q2
$1.26M Buy
8,247
+281
+4% +$43.2K 0.41% 47
2025
Q1
$1.32M Sell
7,966
-187
-2% -$29.3K 0.5% 46
2024
Q4
$1.18M Buy
8,153
+1,151
+16% +$178K 0.43% 50
2024
Q3
$1.13M Hold
7,002
0.42% 51
2024
Q2
$1.02M Sell
7,002
-94
-1% -$14K 0.41% 54
2024
Q1
$1.12M Sell
7,096
-297
-4% -$47.3K 0.5% 46
2023
Q4
$1.16M Sell
7,393
-2,087
-22% -$320K 0.57% 46
2023
Q3
$1.48M Sell
9,480
-888
-9% -$147K 0.77% 37
2023
Q2
$1.72M Sell
10,368
-449
-4% -$72.5K 0.86% 32
2023
Q1
$1.68M Buy
10,817
+1,000
+10% +$161K 0.87% 34
2022
Q4
$1.73M Buy
9,817
+25
+0.3% +$4.32K 1.02% 32
2022
Q3
$1.6M Buy
9,792
+425
+5% +$71.9K 0.93% 30
2022
Q2
$1.66M Buy
9,367
+26
+0.3% +$4.63K 1.01% 29
2022
Q1
$1.66M Buy
9,341
+75
+0.8% +$12.8K 0.83% 38
2021
Q4
$1.58M Sell
9,266
-108
-1% -$17.7K 0.78% 37
2021
Q3
$1.51M Buy
9,374
+1
+0% +$171 0.77% 37
2021
Q2
$1.54M Buy
9,373
+714
+8% +$118K 0.77% 36
2021
Q1
$1.42M Buy
8,659
+251
+3% +$40.6K 0.8% 34
2020
Q4
$1.32M Buy
8,408
+1
+0% +$148 0.78% 35
2020
Q3
$1.25M Buy
8,407
+2
+0% +$296 0.78% 35
2020
Q2
$1.18M Buy
8,405
+101
+1% +$14.7K 0.91% 35
2020
Q1
$1.09M Sell
8,304
-374
-4% -$53.1K 0.98% 27
2019
Q4
$1.27M Buy
8,678
+1
+0% +$136 0.93% 30
2019
Q3
$1.12M Sell
8,677
-123
-1% -$16.2K 0.94% 30
2019
Q2
$1.15M Sell
8,800
-311
-3% -$43K 0.91% 30
2019
Q1
$1.27M Sell
9,111
-1,587
-15% -$213K 1.1% 29
2018
Q4
$1.38M Buy
10,698
+1
+0% +$139 1.52% 19
2018
Q3
$1.48M Sell
10,697
-721
-6% -$95.8K 1.33% 21
2018
Q2
$1.39M Buy
11,418
+1
+0% +$125 1.33% 22
2018
Q1
$1.46M Sell
11,417
-1,599
-12% -$216K 1.5% 20
2017
Q4
$1.82M Buy
+13,016
New +$1.81M 1.83% 17

Other funds holding JNJ

Congress Park Capital's JNJ Position: Q2 2026 in Review

Congress Park Capital reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, selling an estimated $26.3K and leaving 6,838 shares worth $1.74M. The position accounts for 0.47% of the portfolio, ranked #46.

Congress Park Capital first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.82M in Q4 2017. 2,273 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Congress Park Capital held 6,838 shares of Johnson & Johnson worth $1.74M as of Q2 2026.
  • Congress Park Capital sold 113 Johnson & Johnson shares in Q2 2026, an estimated $26.3K.
  • Johnson & Johnson made up 0.47% of Congress Park Capital's portfolio in Q2 2026, its #46 holding.
  • Congress Park Capital first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
  • Congress Park Capital's Johnson & Johnson position peaked at $1.82M in Q4 2017.
  • 2,273 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Congress Park Capital's 13F filing for Q2 2026, filed 14 Jul 2026.